ABA Authorization Denial Appeals for 97153: Medical Necessity Template

Across the roughly 50 behavioral health and ABA practices we support in revenue cycle, the single most consistent revenue leak we see right now is not credentialing lag or billing errors. It is the first-level authorization denial on CPT 97153 (Adaptive Behavior Treatment by Protocol) that practices accept without filing a formal medical necessity appeal. The denial arrives, the practice downcodes or writes off the session, and somewhere between $180 and $220 per hour of billable service disappears without a fight.

That pattern compounds fast. A mid-sized ABA practice billing 400 to 600 units of 97153 per week and accepting a 12 to 15 percent authorization denial rate without appeal is walking away from $85,000 to $130,000 annually in recoverable revenue. We built this guide because we want your RCM director to have a working framework on their desk by tomorrow morning.

Why 97153 Draws Medical Necessity Denials More Than Any Other ABA Code

CPT 97153 covers direct one-on-one ABA therapy delivered by a technician under a BCBA’s supervision. It is high-frequency, high-volume, and high-cost from a payer’s actuarial perspective. In 2026, commercial payers are aggressively auditing authorization requests for 97153 on three primary grounds:

• Insufficient baseline data: The authorization packet lacks quantified functional behavior assessment scores or VB-MAPP/ABLLS-R baseline levels.
• Skill acquisition versus maintenance confusion: Payers deny claims when documentation reads as if the patient is maintaining existing skills rather than acquiring new ones, triggering a “not medically necessary” determination.
• Hours justification: Requests for 20-plus hours per week are denied without a clear link between intensity and functional impairment severity.

What we see at the practices we manage is that the denial letter frequently cites a clinical criteria set, most commonly Magellan’s ABA Level of Care guidelines or Optum’s ABA Medical Necessity Criteria. Your appeal must respond to the specific criteria cited, not to a generic narrative about autism treatment benefits.

The Core Medical Necessity Appeal Framework for 97153

A winning first-level appeal for a denied 97153 authorization has four mandatory structural components. Miss any one of them and you are writing a letter that reads like a complaint rather than a clinical argument.

1. Diagnosis and Functional Severity Anchor

Open with the ICD-10 diagnosis (F84.0 for Autism Spectrum Disorder is most common; include any comorbid codes such as F90.2, F41.1, or R62.50 where accurate) and immediately tie it to a standardized severity score. CARS-2, ADOS-2 composite scores, or Vineland-3 adaptive behavior composite scores carry the most weight with payer medical directors. State the score, state the normative comparison, and state the functional impact on daily living in measurable terms.

2. Treatment Plan Specificity

Every hour of 97153 you are defending must map to a specific, measurable treatment goal. “Improve communication skills” fails. “Increase mand frequency from a baseline of 3 independent mands per 30-minute session to 15 mands per 30-minute session as measured by frequency data across three consecutive probes” passes. Attach the BCBA-authored treatment plan with goal-level data tables. If your treatment plan is not written at this level of specificity, the denial is a documentation problem, not a payer problem.

3. Progress Data or Prognosis Statement

For re-authorization appeals (as opposed to initial authorization), include session-level data graphs showing trajectory. For initial authorization appeals, include the BCBA’s clinical prognosis statement with a projected timeline to goal mastery. Payers are looking for evidence that ABA at the requested intensity will produce measurable change within the authorization period, typically 90 to 180 days.

4. Medical Necessity Criteria Match

Pull the exact clinical criteria language from the denial letter. Quote it in your appeal. Then provide a bullet-point clinical response to each criterion, citing the attached documentation by exhibit. This is the step most in-house billing teams skip, and it is the step that separates a 40 percent overturn rate from a 70 to 75 percent overturn rate at the practices we manage.

POS Codes, Modifiers, and Documentation That Trigger Fewer Denials Upstream

We want to be direct about prevention, because appeals are expensive to work. For 97153 billed in a clinic setting, POS 11 is correct. For home-based services, POS 12. Mixing these without modifier support is one of the most common technical denial triggers we audit. When a BCBA supervisor is present and direct, the correct companion code is 97155; when the BCBA is supervising remotely or indirectly, that distinction must be documented in the clinical note or you will face a bundling denial on 97153 and 97155 submitted together.

Modifier 96 (Habilitative Services) versus modifier 97 (Rehabilitative Services) also matters for certain commercial plans. For most ABA with ASD diagnosis, modifier 96 is correct, but we see practices in states with specific habilitative benefit mandates mis-applying modifier 97, which creates automatic claim-level denials on some BCBSA affiliate plans.

When to Escalate to an External Appeal and MHPAEA Argument

If your first-level internal appeal on a 97153 denial is upheld, do not stop there. A substantial portion of ABA authorization denials involve payers applying more restrictive medical necessity criteria to ABA than they apply to comparable medical or surgical services. That is a federal parity violation under the Mental Health Parity and Addiction Equity Act. We have written in detail about how practices are leaving significant money on the table by not pursuing parity-based appeals: read our full MHPAEA appeals breakdown here.

An external independent medical review combined with a written parity demand letter changes the payer’s calculus. External IMR overturn rates for behavioral health denials nationally run between 40 and 60 percent depending on state, and payers know that a sustained external overturn creates regulatory exposure. Use that leverage.

What a Denial Appeals Tracking System Needs to Capture

We cannot overstate how important denial tracking infrastructure is to making appeals scalable. Every 97153 denial should be logged with the following fields before the appeal is worked: payer name, denial reason code, denial criteria cited, date of service range, authorized versus requested units, assigned BCBA, and treating technician credential level. Without this data, you cannot identify systemic patterns and you cannot build a payer-specific appeals library that improves overturn rates over time.

Practices that track at this level see their overturn rates improve by 15 to 20 percentage points within six months simply because they stop re-writing appeals from scratch and start refining arguments that already work with specific payer medical directors.

The Dollar Math on Working Every Denial

At a current commercial rate of approximately $18 to $22 per unit for 97153, a single denied authorization covering 40 units per week over a 90-day authorization period represents roughly $2,600 to $3,200 in at-risk revenue per patient episode. A practice with 30 active ABA patients and a 12 percent denial rate that is not appealing is leaving approximately $9,400 to $11,500 per month on the table. Annualized and compounded across a patient census growth of 10 to 15 percent, that is a material RCM gap that shows up directly in operating margin.

Working denials is not administrative overhead. It is revenue recovery with a measurable ROI, and practices that treat their appeals function as a clinical revenue function rather than a billing afterthought consistently outperform their peers on net collection rate by 8 to 12 percentage points.

Start with a Denial Audit Before You Build the Template

If you are not certain what percentage of your 97153 denials are being appealed, what your current overturn rate is by payer, or whether your appeal letters are addressing the cited clinical criteria, you need that baseline before you can improve it. We offer a free 30-day denial audit for ABA and behavioral health practices that shows you exactly where you are leaking revenue and what a realistic recovery trajectory looks like. Schedule your free denial audit here and we will have a preliminary analysis of your 97153 denial pattern in front of you within one week.